Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of Flunisolide Hfa (Aerospan) in Adult and Adolescent Patients

Trial Profile

Efficacy of Flunisolide Hfa (Aerospan) in Adult and Adolescent Patients

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 07 Jul 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Flunisolide (Primary)
  • Indications Asthma
  • Focus Therapeutic Use

Most Recent Events

  • 18 May 2016 Results assessing HPA-axis functioning from two 12-week trials presented at the 112th International Conference of the American Thoracic Society
  • 12 Nov 2015 Status changed from not stated to completed.
  • 05 Nov 2010 New trial record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top